Biotech

All Articles

Lilly, Haya ink $1B biobuck excessive weight pact to explore black genome

.Eli Lilly's search for excessive weight targets has actually led it to the black genome. The Big Ph...

ArsenalBio raises $325M, pivots out of previous lead asset

.Toolbox Biosciences is carrying on up. The cell treatment company has actually added $325 million i...

Lilly- backed weight loss biotech data IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has submitted...

Aelis' marijuana usage medicine flunks stage 2b, driving Indivior to reconsider $100M option

.Aelis Farma's hopes of safeguarding a fast, positive choice on a $100 million possibility payment h...

ProKidney halts period 3 test certainly not required for cell treatment approval

.ProKidney has actually stopped among a set of period 3 tests for its cell treatment for kidney ailm...

Vaxcyte climbs on 'spectacular' 31-valent PCV gain against Pfizer

.Vaxcyte introduced what experts referred to as "spectacular" stage 1/2 information for its 31-valen...

Recursion's mind condition trial presents scant evidence of efficacy

.Recursion has actually discovered with a very early examination of its own tech-enabled strategy to...

Acepodia, Pfizer click with each other for chemistry-based tissue treatment

.Call it a scenario of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning science, ...

Praxis epilepsy drug lowers seizures in phase 2 trial

.Practice Precision Medicines has actually racked up an additional midphase succeed in epilepsy this...

Three directors surrender as Dyne posts blended records for DMD prospect

.After escaping a clinical grip many years back, Dyne Rehab has shown brand-new period 1/2 records f...